1. Home
  2. HEQ vs MXCT Comparison

HEQ vs MXCT Comparison

Compare HEQ & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Hedged Equity & Income Fund of Beneficial Interest

HEQ

John Hancock Hedged Equity & Income Fund of Beneficial Interest

HOLD

Current Price

$11.53

Market Cap

134.7M

Sector

Finance

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.79

Market Cap

160.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HEQ
MXCT
Founded
N/A
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.7M
160.0M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
HEQ
MXCT
Price
$11.53
$0.79
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
45.7K
1.5M
Earning Date
01-01-0001
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$38,627,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.23
$0.64
52 Week High
$11.55
$3.69

Technical Indicators

Market Signals
Indicator
HEQ
MXCT
Relative Strength Index (RSI) 76.52 30.10
Support Level $10.55 $0.75
Resistance Level N/A $1.81
Average True Range (ATR) 0.08 0.07
MACD 0.02 0.02
Stochastic Oscillator 100.00 46.49

Price Performance

Historical Comparison
HEQ
MXCT

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: